Page 173 - TBE_Book_V2_2019
P. 173

Chapter 9: Immunology of TBEV infection



          Innate response and its antagonism          Innate cellular responses in
          by TBEV                                     circulation during TBE

          Many  viruses  induce  activation  of  PRR  and
          subsequent IFN signalling within hours of viral   NK cells
          infection. Similarly to other viruses, TBEV may
                                                      Natural  killer  (NK)  cells  are  cytotoxic  innate
          also have many mechanisms to interfere with
          or evade the innate immunity. TBEV as a single  lymphoid  cells  that  are  an  important  part  of
          -stranded RNA (ssRNA) virus produces double-  the  immune  response  against  viruses  and
                                                      tumor  cells.  NK  cells  represent  a  distinct
          stranded  RNA  (dsRNA)  intermediates  during
                                                      population of lymphocytes that lack CD3 and
          replication.  One  of  the  earliest  immune
                                                      express  CD56.  The  two  main  NK  cell
          evasion strategies by TBEV is to hide its dsRNA
          from  the  cytoplasmic  PRRs  within  the  host   populations  in  peripheral  blood  of  healthy
                                                                                  dim
                                                                                        +
                                               38
          cells by rearranging internal cell membranes.    individuals are the cytotoxic CD56 bright CD16  NK
                                                                                        -
                                                      cells, and the less cytotoxic CD56  CD16  NK
          Inaccessibility  of  dsRNA  for  cytoplasmic  PRRs
                                                      cells  which  produce  larger  amounts  of
          delays  the  activation  of  interferon  regulatory              42
          factor 3 (IRF-3), a key transcriptional regulator   cytokines upon activation.  The ability of NK
          of  type  I  IFN  response.  This  results  in  a   cells  to  distinguish  between  normal  and
          subsequent 24h delay of IFN production giving   infected  cells  is  partly  dependent  on  the
                                                      surface  MHC  class  I  expression  levels.  In
          an  opportunity  for  TBEV  to  replicate
                    38
          unhindered.                                 addition,  NK  cells  express  multiple  activating
                                                      and inhibitory receptors, and the state of NK
          Effective  and  early  IFN  responses  are  critical   activation  or  tolerance  is  dependent  on  a
                                                      balance  of  the  engagement  of  these
          during  viral infection, thus active antagonism     43
                                                      receptors.   NK  cell  cytotoxicity  is  mediated
          of  host  proteins  involved  in  IFN  responses  is
                                                      via  three  main  pathways:  1)  cell  lysis  of
          another common viral mechanism of evasion.
          Viruses  often  use  their  own  proteins  to   infected cells using perforin- and granzyme, 2)
          directly interact with and inhibit IFN signalling   Fas ligand–mediated induction of apoptosis, 3)
                                                      antibody-dependent  cellular  cytotoxicity,  NK
          molecules.  Studies  on  Langat  virus  have
                                                      cells  also  produce  cytokines  and  chemokines
          shown that viral nonstructural protein 5 (NS5)
                                                      for  communication  with  surrounding  cells,
          is an IFN antagonist and inhibits the JAK-STAT
          signal  transduction  pathway  by  blocking  the   thereby also bridging the innate and adaptive
                                                                     44
          phosphorylation  of  STAT1,  STAT2,  Tyk2  and   immune response.
              39
          Jak1.   Similarly,  TBEV  NS5  protein  was  also
                                                      In  patients  suffering  from  TBE,  NK  cells  are
          found to block the phosphorylation of STAT1
          by  binding  to  the  host  membrane  protein   present in both peripheral blood and the CSF
          scribble  (hScrib)  resulting  in  inhibition  of   with higher percentages of NK cells residing in
                                                               45
                                 40
          downstream  IFN  signalling.   Another  known   the  blood.   Even  though  the  virus  is  not
                                                      detected  during  the  second  phase  of  TBE,
          target  of  TBEV  NS5  is  host  protein  prolidase
                                                      increased  levels  of  cytokines  that  either
          (PEPD).  Interaction  of  NS5  with  PEPD  is
          associated with decreased surface expression   activate  or  are  produced  by  NK  cells  are
                                                                     46
          of type I IFN receptor subunit IFNAR1 resulting   detected  in  blood.   In  addition,  NK  cells  are
                                 41
          in  reduced  ISG  expression.   These  findings   shown  to  be  activated  at  early  time  points
                                                      during the second phase of TBE (Figure 2). The
          highlight  an  important  role  of  TBEV  NS5
                                                      TBEV-induced   NK   cell   activation   was
          protein  as  a  strong  antagonist  of  type  I  IFN
          response.                                   predominantly seen in more differentiated NK
                                                               +
                                                                    dim
                                                      cells  (CD57 CD56  ).  The  activated  NK  cells
                                                  168
                                                  168
   168   169   170   171   172   173   174   175   176   177   178